stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G/A - PharmaCyte Biotech, Inc. | StockGist | StockGist
Companies
PMCB
SCHEDULE 13G/A
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
PMCB
SCHEDULE 13G/A
SCHEDULE 13G/A
Beneficial Ownership
Amendment
PharmaCyte Biotech, Inc.
Filed Nov 7, 2025
Accepted Nov 6, 2025, 7:00 PM ET
PMCB
CIK 0001157075
View on SEC.gov
Company Profile
0001213900-25-107726
Beneficial Ownership Report
Passive Investment
Shares Owned
695,715
Reporting Person
PharmaCyte Biotech, Inc.
Person Type
HC
CUSIP: 717512X20